Clinical Trials on Estrogen Receptor Positive Breast Cancer in France

Total 1255 results

Carrick Therapeutics Limited
Berlin-Chemie AG Menarini Group

Recruiting

A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer (SUMIT-ELA)

Breast Cancer | Metastatic Breast Cancer | Locally Advanced Breast Cancer

United States, Spain, France, United Kingdom
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Feasibility Study: Yoga Educational Project (SKYPE)

Breast Cancer

France
Centre Antoine Lacassagne

Completed

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

Breast Cancer

France
Centre Oscar Lambret

Completed

Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer (MAMMOSITE2)

Breast Cancer

France
Institut Curie

Completed

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

Breast Cancer

France
Centre Oscar Lambret

Unknown

Study of Blood Samples in Patients With Breast Cancer

Breast Cancer

France
Fondation Hôpital Saint-Joseph

Active, not recruiting

Evaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment. (HYGEE)

Breast Cancer

France
Institut Paoli-Calmettes
UNICANCER - Le Groupe génétique et cancer (GGC)

Recruiting

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation (GENEPSO)

Breast Cancers | Ovarian Cancers

France
Hoffmann-La Roche

Completed

An Observational Follow-up Study of 1st-Line Treatment With Herceptin (Trastuzumab) in Patients With Metastatic Breast Cancer (Post-HERMINE)

Breast Cancer

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Medico Economic Study, Comparing Intrabeam® on Surgical Resection Bed to Conventional Surgery + EBRT, in Breast Cancer (RIOP-SEIN)

Menopausal Patients | Low-risk Breast Cancer

France
Centre Jean Perrin

Completed

Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2) (MetaCa2)

Breast Cancer | Hormonal Therapy

France
International Agency for Research on Cancer
Centre Leon Berard

Not yet recruiting

Virtual RealiTy and mUsic in the Oncology SEtting - Phase 1 (VRtuose1)

Breast Cancer

France
Centre Francois Baclesse

Recruiting

Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer (WEBAPPAC)

Breast Cancer | Web-application | Hormono Therapy

France
Centre Hospitalier Universitaire, Amiens

Recruiting

Step by Step After Cancer (SBSAC)

Breast Cancer

France
Hospices Civils de Lyon

Withdrawn

Effect of Physical Activity in Patients With Breast Cancer. (APACAM)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe
UR 3072 - Mitochondrie, Stress oxydant et Protection musculaire

Completed

Characterization of Neuromuscular Function and Fatigue After Breast Cancer Treated With Adjuvant Chemotherapy (PROTECT-04) (PROTECT-04)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Study in Leptomeningeal Metastases of Breast Cancer (LCS Bio Sein)

Breast Cancer

France
University Hospital, Limoges

Completed

Adapted Physical Activity Effect and Fatigue in Patients With Breast Cancer (SAPA)

Breast Cancer

France
Institut Paoli-Calmettes

Suspended

Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer (PIKHER2)

Breast Cancer

France
ARCAGY/ GINECO GROUP

Completed

Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer

Breast Cancer

France
University Hospital, Tours

Completed

Ultrasound and Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response

Breast Cancer

France
Institut Cancerologie de l'Ouest

Not yet recruiting

Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients (NEOEPICURE)

Breast Cancer

France
UNICANCER
Novartis

Completed

Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative (GEP14-LEECAP)

Breast Cancer

France
Institut Paoli-Calmettes

Completed

Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast Cancer (AVASTEM)

Breast Cancer

France
Lytix Biopharma AS
ICON plc; Theradex

Completed

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

Melanoma | Lymphoma | Cancer | Breast Cancer | Head and Neck Cancer | Triple-Negative Breast Cancer

United Kingdom, France, Norway, Belgium, Italy
Hopital Nord Franche-Comte

Recruiting

Smart Bra for Diagnosing Breast Cancer (CBRA)

Breast Cancer | Medical Device

France
Centre Hospitalier Universitaire, Amiens

Unknown

Involvement of the Inositol-trisphosphate Receptor in Invasive or Migratory-type Breast Cancers (CarcIno)

Breast Cancer | Inosine Triphosphatase

France
Novartis Pharmaceuticals

Completed

Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

Breast Cancer

France
Centre Hospitalier Universitaire de Nīmes

Recruiting

Evaluation of Changes in the Immunological Microenvironment Surrounding Subcutaneous Breast Cancer Metastases After Liquid Nitrogen Cryotherapy (CRIMCAS)

Breast Cancer

France
University Hospital, Strasbourg, France

Completed

Mindfulness-based Stress Reduction (MBSR) Program Combined With Endurance Exercise Training: a Help in Treatment for Breast Cancer (MBSR)

Breast Cancer

France
Centre Antoine Lacassagne

Completed

Single Fraction Elderly Breast Irradiation (SiFEBI) (SIFEBI)

Breast Cancer

France
University Hospital, Limoges

Completed

Adapted Physical Activity Effect on Aerobic Function and Fatigue at Home in Patients With Breast Cancer Treated in Adjuvant or Neoadjuvant Phase (APAC)

Breast Cancer

France
Institut Curie

Terminated

Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer (OPTICOACH)

Breast Cancer | Surgery

France
Institut du Cancer de Montpellier - Val d'Aurelle

Unknown

Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE) (BIORISE)

Breast Cancer

France
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Seagen Inc.

Recruiting

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC... and other conditions

United States, Canada, Puerto Rico
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology (SAHARA-04)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant Treatment (APAD)

Breast Cancer

France
Institut Claudius Regaud

Completed

Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer (MIRHO)

Breast Cancer

France
Institut Claudius Regaud

Active, not recruiting

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm (COCABIO000)

Triple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mm

France
Institut Cancerologie de l'Ouest

Recruiting

Persistent Organic Pollutants and Breast Cancers (POPCASE) (POPCASE)

Breast Cancer

France
University Hospital, Tours

Completed

Evaluation of the Short Message Service Effectiveness in the Screening Invitation Strategy for Breast Cancer (USIMaPI) (USIMaPI)

Breast Cancer

France
Centre Hospitalier Departemental Vendee

Unknown

Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer (BEAUTY)

Breast Cancer

France
Institut Curie

Recruiting

Digital Phenotyping in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy (NeoFit)

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity (ARMONIC)

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer (STEREO-SEIN)

Breast Cancer

France
Bolt Biotherapeutics, Inc.
Bristol-Myers Squibb

Active, not recruiting

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

HER2-positive Breast Cancer | HER2-positive Colorectal Cancer | HER2-positive Solid Tumors | HER2-positive Gastroesophageal Cancer | HER2-positive Endometrial Cancer

France, United States, Spain, Korea, Republic of, Italy
Center Eugene Marquis

Recruiting

Prevention of Sequelae Pain After Breast Cancer Surgery by Self-massages and Self Stretching. Impact of Learning Workshops. (ESTAUVAL)

Breast Cancer | Surgery

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer (MEDEA)

Overweight or Obese Breast Cancer Patients

France
UNICANCER
Agendia

Recruiting

Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk (LESS)

Breast Cancer

France

3

Subscribe